VHT Insider Trading

Insider Ownership Percentage: 25.03%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Volpara Health Technologies Insider Trading History Chart

This chart shows the insider buying and selling history at Volpara Health Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Volpara Health Technologies Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for VHT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Volpara Health Technologies Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/17/2023Mark BouwInsiderIssued450,000A$1.30A$585,000.00
6/1/2023Teri ThomasInsiderExercise75,280A$0.76A$57,212.80
2/16/2023Roger AllenInsiderExercise300,000A$0.50A$150,000.00
6/22/2022John DiddamsInsiderBuy30,000A$0.45A$13,560.00
6/15/2022Paul ReidInsiderBuy115,000A$0.58A$66,930.00
8/18/2021Roger AllenInsiderIssued150,000A$1.33A$199,500.00
6/10/2021Monica SainiInsiderSell100,000A$1.22A$121,500.00
See Full Table

SEC Filings (Institutional Ownership Changes) for Volpara Health Technologies (ASX:VHT)

20.51% of Volpara Health Technologies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Volpara Health Technologies logo
Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand. The company offers Volpara Analytics, a software that optimize breast cancer screening operations; Volpara Live, which provides instant patient-based image quality feedback; Volpara Lung, a patient management software that streamlines lung screening workflow; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses TC8 to calculate patients' risk of developing breast cancer; Volpara Risk Pathways, a program for identifying and managing high-risk breast, lung, ovarian, and colorectal cancer screening patients; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products; and Volpara Thumbnail, an image-enhanced patient notification letters. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. It operates in North America, the Asia Pacific, Europe, the Middle East, and Africa. Volpara Health Technologies Limited has a strategic relationship with RevealDx. The company was incorporated in 2009 and is headquartered in Wellington, New Zealand.
Read More on Volpara Health Technologies

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A


434,964 shs

Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Volpara Health Technologies?

Volpara Health Technologies' top insider investors include:
  1. John Diddams (Insider)
  2. Mark Bouw (Insider)
  3. Paul Reid (Insider)
  4. Roger Allen (Insider)
  5. Teri Thomas (Insider)
Learn More about top insider investors at Volpara Health Technologies.